home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Neon Therapeutics Reports Second Quarter 2019 Financial Results
Neon Therapeutics Reports Second Quarter 2019 Financial Results
Post navigation
Previous Post
Previous
Blueprint Medicines Reports Second Quarter 2019 Financial Results
Next Post
Next
Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST